A three-dimensional mathematical model for drug delivery from drug-eluting stents
Authors
Abstract:
Current drug-eluting stent (DES) technology is not optimized with regard to the pharmacokinetics of drug release, more research on the drug-eluting stent design and flux of drug release to the arterial wall is necessary. Considering a three-dimensional (3D) cylindrical mathematical model, a novel free drug mass transfer release has been formulated and applied for better estimation of the drug concentration in the tissue. The transport equations involved both convection and diffusion equations. Besides, a reversible reaction in the arterial wall was considered. The present model was solved by an appropriate numerical simulation method and the predicted results were compared with in vivo data. To find out the rate-limiting step, the time scale analysis was also applied. The obtained results showed that the binding process is more limited by convection and diffusion, where convection is the rate-controlling step. It is also demonstrated that the presented approach has advantages over the prior free drug mass transfer models, including better data prediction and satisfying mass transfer consistency.
similar resources
Mathematical Modeling and Simulation of Intravascular Drug Delivery from Drug-Eluting Stents with Biodegradable PLGA Coating
Drug-eluting stents (DES) are commonly used in coronary angioplasty procedures. A DES elutes drug compounds from a thin polymeric coating into the surrounding coronary artery tissue to reduce in-stent restenosis (a significant lumen loss due to growth of vascular tissue). Biodurable (non-erodible) polymers are often used in the current DES coatings, which stay permanently in the patients. While...
full textOptimization of Drug Delivery by Drug-Eluting Stents
Drug-eluting stents (DES), which release anti-proliferative drugs into the arterial wall in a controlled manner, have drastically reduced the rate of in-stent restenosis and revolutionized the treatment of atherosclerosis. However, late stent thrombosis remains a safety concern in DES, mainly due to delayed healing of the endothelial wound inflicted during DES implantation. We present a framewo...
full textNew Drug-Eluting Stents
The introduction of drug-eluting stents (DES) has rapidly and profoundly affected the field of interventional cardiology, and DESs are now used in a majority of intracoronary stenting procedures. As a result of the innumerable “trial-and-error” endeavors, DESs have emerged as a potential solution for solving the problem of restenosis. DESs are coated stents capable of releasing single or multip...
full textDrug-Eluting Stents
n the history of percutaneous coronary intervention, drug-eluting stents (DES) are recognized as revolutionary technologies with their unique ability to provide both mechanical and biological solutions simultaneously to the target lesion. While the clinical success of DES depends on these 2 properties, the ability of the operator to properly deploy the device is also of utmost importance. Altho...
full textMy Resources
Journal title
volume 12 issue 4
pages 15- 27
publication date 2015-10-01
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023